Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001140361-13-028384)

Filing Details

Accession Number:: 0001140361-13-028384
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-07-18 17:47:53
Reporting Period:: 2013-07-16

Filing Date:: 2013-07-18
Accepted Time:: 2013-07-18 17:47:53
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1140028	Talon Therapeutics Inc.	TLON	Pharmaceutical Preparations (2834)	320064979

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
929408	Warburg Pincus & Co.	450 Lexington Avenue New York NY 10017		Yes	No	Yes	No
1162870	Warburg Pincus Llc	450 Lexington Avenue New York NY 10017		No	No	Yes	No
1220638	P. Joseph Landy	C/O Warburg Pincus &Amp; Co. 450 Lexington Avenue New York NY 10017		No	No	Yes	No
1239318	R Charles Kaye	C/O Warburg Pincus &Amp; Co. 450 Lexington Avenue New York NY 10017		No	No	Yes	No
1322709	Warburg Pincus Partners Llc	C/O Warburg Pincus &Amp; Co. 450 Lexington Avenue New York NY 10017		Yes	No	Yes	No
1414561	Warburg Pincus X, L.p.	C/O Warburg Pincus &Amp; Co. 450 Lexington Avenue New York NY 10017		Yes	No	Yes	No
1414564	Warburg Pincus X Llc	C/O Warburg Pincus &Amp; Co. 450 Lexington Avenue New York NY 10017		Yes	No	Yes	No
1414565	Warburg Pincus Private Equity X, L.p.	C/O Warburg Pincus &Amp; Co. 450 Lexington Avenue New York NY 10017		Yes	No	Yes	No
1451560	Warburg Pincus X Partners, L.p.	C/O Warburg Pincus &Amp; Co. 450 Lexington Avenue New York NY 10017		Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.001 Par Value ("Common Stock")	Acquisiton	2013-07-16	65,016,890	$0.74	65,016,890	No	4	C	Indirect	See footnotes
Common Stock	Acquisiton	2013-07-16	37,775,503	$0.30	102,792,393	No	4	C	Indirect	See footnotes
Common Stock	Acquisiton	2013-07-16	49,537,551	$0.35	152,329,944	No	4	C	Indirect	See footnotes
Common Stock	Disposition	2013-07-16	152,329,944	$0.06	0	No	4	S	Indirect	See footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See footnotes
No	4	C	Indirect	See footnotes
No	4	C	Indirect	See footnotes
No	4	S	Indirect	See footnotes

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A-1 Convertible Preferred Stock, $0.001 Par Value	Disposition	2013-07-16	360,000	$100.00	63,037,004	$0.74
Common Stock	Series A-1 Preferred Stock	Disposition	2013-07-16	11,307	$100.00	1,979,886	$0.74
Common Stock	Series A-2 Convertible Preferred Stock, $0.001 Par Value	Disposition	2013-07-16	99,000	$100.00	37,775,503	$0.30
Common Stock	Series A-3 Convertible Preferred Stock, $0.001 Par Value	Disposition	2013-07-16	27,000	$100.00	8,460,526	$0.35
Common Stock	Series A-3 Preferred Stock	Disposition	2013-07-16	54,000	$100.00	16,737,865	$0.35
Common Stock	Series A-3 Preferred Stock	Disposition	2013-07-16	27,000	$100.00	8,189,762	$0.35
Common Stock	Series A-3 Preferred Stock	Disposition	2013-07-16	54,000	$100.00	16,149,398	$0.35
Series A-3 Convertible Preferred Stock	Right to Acquire Series A-3 Convertible Preferred Stock	Disposition	2013-07-16	420,000	$0.00	420,000	$100.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2010-06-07		No	4	C	Indirect
0	2010-09-10		No	4	C	Indirect
0	2012-01-09		No	4	C	Indirect
0	2012-07-03		No	4	C	Indirect
0	2012-08-17		No	4	C	Indirect
0	2012-11-14		No	4	C	Indirect
0	2013-01-11		No	4	C	Indirect
0	2012-01-09		No	4	J	Indirect

Footnotes

See Exhibit 99.1; Note 1.
See Exhibit 99.1; Note 2.
See Exhibit 99.1; Note 3.
See Exhibit 99.1; Note 4.
See Exhibit 99.1; Note 5.